A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that stress-induced IBS symptoms could be alleviated by drugs that regulate ...
StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biotechnology ...
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback